drugset / Trial / NCT00151749
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Timeline
- Start
- 2004-06
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colesevelam | Other / unclassified | 3.75 g | — |